Provided by Tiger Trade Technology Pte. Ltd.

Galapagos NV

33.36
-0.0200-0.06%
Post-market: 33.360.00000.00%16:10 EST
Volume:71.19K
Turnover:2.38M
Market Cap:2.20B
PE:-4.30
High:33.61
Open:33.38
Low:33.17
Close:33.38
52wk High:37.78
52wk Low:22.36
Shares:65.90M
Float Shares:65.05M
Volume Ratio:0.70
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7644
EPS(LYR):1.16
ROE:-16.72%
ROA:-5.19%
PB:0.76
PE(LYR):28.66

Loading ...

Analysts Conflicted on These Healthcare Names: Galapagos (GLPG), Pharvaris (PHVS) and Stevanato Group (STVN)

TIPRANKS
·
Jan 26

AngioDynamics, Microchip Technology And 3 Stocks To Watch Heading Into Tuesday

Benzinga
·
Jan 06

Galapagos to Wind Down Cell Therapy Activities, Impacting 365 Employees

Dow Jones
·
Jan 06

Galapagos to Look At Strategic Alternatives After Drug Doesn't Meet Trial Goal

Dow Jones
·
Dec 19, 2025

Galapagos Reports Topline Data From Two Trials With GLPG3667 in Dermatomyositis, Systemic Lupus Erythematosus

MT Newswires Live
·
Dec 19, 2025

Galapagos NV Receives Transparency Notifications from Bank of America

TIPRANKS
·
Nov 26, 2025

RBC Adjusts Price Target on Galapagos to $32 From $28, Maintains Sector Perform Rating

MT Newswires Live
·
Nov 08, 2025

Galapagos NV expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
Nov 03, 2025

Galapagos NV Strengthens Board with Strategic Appointments

TIPRANKS
·
Oct 31, 2025

RBC Raises Price Target on Galapagos to $28 From $27, Keeps Sector Perform Rating

MT Newswires Live
·
Oct 22, 2025

Galapagos Nv : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $40 From $29

THOMSON REUTERS
·
Oct 22, 2025

Galapagos (GLPG) Gets a Hold from RBC Capital

TIPRANKS
·
Oct 22, 2025

Galapagos Raised to Outperform From Market Perform by Leerink Partners

Dow Jones
·
Oct 22, 2025

Leerink upgrades Galapagos on confidence after cell therapy exit

TIPRANKS
·
Oct 22, 2025

Top Premarket Decliners

MT Newswires Live
·
Oct 21, 2025

Galapagos Shares Sink on Plans to Wind Down Cell-Therapy Business

Dow Jones
·
Oct 21, 2025

Galapagos intends to wind down cell therapy business

TIPRANKS
·
Oct 21, 2025

Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Pharvaris (PHVS) and Stevanato Group (STVN)

TIPRANKS
·
Oct 13, 2025

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Stevanato Group (STVN) and Galapagos (GLPG)

TIPRANKS
·
Oct 06, 2025

Galapagos Exploring Divesting From Cell Therapy Business

Dow Jones
·
Oct 02, 2025